SILK Silk Road Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SILK

Price (delayed)

$20.28

Market cap

$794.46M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.44

Enterprise value

$849.88M

Silk Road Medical, Inc.,is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company's flagship procedure, TransCarotid ...

Highlights
SILK's revenue is up by 28% YoY and by 4.2% QoQ
The gross profit is up by 26% year-on-year and by 4.7% since the previous quarter
The company's quick ratio fell by 29% YoY and by 24% QoQ
Silk Road Medical's equity has decreased by 8% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://silkroadmed.com
Peers: NVRO OFIX NURO

Key stats

What are the main financial stats of SILK
Market
Shares outstanding
39.17M
Market cap
$794.46M
Enterprise value
$849.88M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.23
Price to sales (P/S)
4.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.8
Earnings
Revenue
$177.13M
EBIT
-$48.87M
EBITDA
-$45.08M
Free cash flow
-$33.52M
Per share
EPS
-$1.44
Free cash flow per share
-$0.86
Book value per share
$3.88
Revenue per share
$4.56
TBVPS
$6.84
Balance sheet
Total assets
$265.31M
Total liabilities
$114.16M
Debt
$75.63M
Equity
$151.15M
Working capital
$210.55M
Liquidity
Debt to equity
0.5
Current ratio
7.95
Quick ratio
6.77
Net debt/EBITDA
-1.23
Margins
EBITDA margin
-25.4%
Gross margin
71.7%
Net margin
-31.5%
Operating margin
-33.5%
Efficiency
Return on assets
-21.3%
Return on equity
-36.1%
Return on invested capital
-17.4%
Return on capital employed
-20.8%
Return on sales
-27.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SILK stock price

How has the Silk Road Medical stock price performed over time
Intraday
7.3%
1 week
13.93%
1 month
14.25%
1 year
-51.49%
YTD
65.28%
QTD
10.7%

Financial performance

How have Silk Road Medical's revenue and profit performed over time
Revenue
$177.13M
Gross profit
$127.09M
Operating income
-$59.27M
Net income
-$55.74M
Gross margin
71.7%
Net margin
-31.5%
SILK's revenue is up by 28% YoY and by 4.2% QoQ
The gross profit is up by 26% year-on-year and by 4.7% since the previous quarter
The net margin has grown by 21% year-on-year and by 3.1% since the previous quarter
SILK's operating income is down by 14% year-on-year and by 3% since the previous quarter

Growth

What is Silk Road Medical's growth rate over time

Valuation

What is Silk Road Medical stock price valuation
P/E
N/A
P/B
5.23
P/S
4.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.8
Silk Road Medical's EPS has increased by 6% YoY
The P/B is 66% below the 5-year quarterly average of 15.5 and 16% below the last 4 quarters average of 6.2
Silk Road Medical's equity has decreased by 8% YoY
The stock's price to sales (P/S) is 72% less than its 5-year quarterly average of 16.0 and 26% less than its last 4 quarters average of 6.0
SILK's revenue is up by 28% YoY and by 4.2% QoQ

Efficiency

How efficient is Silk Road Medical business performance
The return on invested capital rose by 46% year-on-year
The company's return on equity rose by 43% YoY but it fell by 2.8% QoQ
The ROA has grown by 29% YoY
Silk Road Medical's return on sales has increased by 23% YoY and by 3.2% QoQ

Dividends

What is SILK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SILK.

Financial health

How did Silk Road Medical financials performed over time
The total assets is 132% greater than the total liabilities
The company's quick ratio fell by 29% YoY and by 24% QoQ
The current ratio has contracted by 24% YoY and by 21% from the previous quarter
The debt is 50% smaller than the equity
The company's debt to equity rose by 9% YoY and by 2% QoQ
Silk Road Medical's equity has decreased by 8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.